SCHEMBL7314567

SCHEMBL7314567

CCOC(=O)[C@H](Cc1ccc(OC2CCN(C)CC2)cc1)N(C(=O)C1CS(=O)(=O)CCN1)S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.34
HRH1 P35367 3/20 0.34
CCR3 P51677 3/20 0.34
KCNH2 Q12809 2/20 0.34
RORC P51449 4/20 0.33
F2 P00734 3/20 0.33
F10 P00742 3/20 0.33
PLG P00747 3/20 0.33
PRSS1 P07477 3/20 0.33
PRSS2 P07478 3/20 0.33
PRSS3 P35030 3/20 0.33
HTR2A P28223 2/20 0.33
ACACB O00763 1/20 0.33
HTR2C P28335 1/20 0.33
FPR2 P25090 1/20 0.33
PROKR1 Q8TCW9 1/20 0.33
ALDH1A1 P00352 2/20 0.33
RORA P35398 1/20 0.33
PKM P14618 1/20 0.33
TRPM8 Q7Z2W7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7327485 0.93 HRH1 (0.36) CYP2D6HRH1CCR3KCNH2RORC
SCHEMBL7068178 0.85 POLB (0.40) ALDH1A1NPSR1L3MBTL1
SCHEMBL5690785 0.80 ENPP3 (0.36) ALDH1A1TP53NPSR1
SCHEMBL3872663 0.80 P2RX7 (0.37) ALDH1A1TP53ALOX15MAPK1NPSR1
SCHEMBL5691009 0.80 MAPT (0.40) ALDH1A1TP53MAPK1
SCHEMBL7321027 0.79 CYP2D6 (0.34) CYP2D6HRH1CCR3KCNH2RORC
SCHEMBL3869306 0.78 P2RX7 (0.36) ALDH1A1TP53ALOX15MAPK1NPSR1
SCHEMBL3877158 0.78 P2RX7 (0.32) ALDH1A1MAPK1
SCHEMBL3870071 0.77 P2RX7 (0.32) ALDH1A1MAPK1
SCHEMBL3870515 0.77 P2RX7 (0.34) ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP claimed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO claimed
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US disclosed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP disclosed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed